AIG
TSBX

American International Group’s Turnstone Biologics TSBX Stock Holding History

American International Group’s Portfolio TSBX Stock Details TSBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,616
Closed -$20K – 2522
2024
Q1 		$20K Buy
7,616
+4,339
+132% +$12.4K ﹤0.01% 2931
2023
Q4 		$8.34K Buy
3,277
+80
+3% +$209 ﹤0.01% 3016
2023
Q3 		$12.6K Buy
+3,197
New +$28.5K ﹤0.01% 3018

Other funds holding TSBX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

American International Group's TSBX Position: Q2 2024 in Review

American International Group sold out of Turnstone Biologics (TSBX) in Q2 2024, closing a stake of 7,616 shares — an estimated $20K sold.

American International Group first reported a position in TSBX in Q3 2023 and held it in 3 quarters. The position peaked at $20K in Q1 2024. 47 funds tracked by Wall St. Rank hold TSBX as of Q2 2024.

  • American International Group reported no remaining Turnstone Biologics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 7,616 Turnstone Biologics shares in Q2 2024, an estimated $20K.
  • American International Group first reported a position in Turnstone Biologics in Q3 2023 and held it in 3 quarters.
  • American International Group's Turnstone Biologics position peaked at $20K in Q1 2024.
  • 47 funds tracked by Wall St. Rank held Turnstone Biologics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.